84 related articles for article (PubMed ID: 9683792)
1. Cyclin A levels, the duration of S phase and sensitivity to a chemotherapeutic agent are altered in fibroblasts cultured on a fibronectin matrix.
Min I; Stubbs MC; Strachan GD; Hall DJ
Int J Oncol; 1998 Sep; 13(3):549-55. PubMed ID: 9683792
[TBL] [Abstract][Full Text] [Related]
2. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
3. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
5. Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.
Jordan-Sciutto KL; Logan TJ; Norton PA; Derfoul A; Dodge GR; Hall DJ
Exp Cell Res; 1997 Nov; 236(2):527-36. PubMed ID: 9367638
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
7. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
Timchenko NA; Wilde M; Darlington GJ
Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
[TBL] [Abstract][Full Text] [Related]
8. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
9. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
10. DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain.
Guida P; Zhu L
Biochem Biophys Res Commun; 1999 May; 258(3):596-604. PubMed ID: 10329431
[TBL] [Abstract][Full Text] [Related]
11. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
13. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
15. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
16. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4.
Orend G; Huang W; Olayioye MA; Hynes NE; Chiquet-Ehrismann R
Oncogene; 2003 Jun; 22(25):3917-26. PubMed ID: 12813465
[TBL] [Abstract][Full Text] [Related]
18. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
Strobeck MW; Fribourg AF; Puga A; Knudsen ES
Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
[TBL] [Abstract][Full Text] [Related]
19. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
20. An early S phase checkpoint is regulated by the E2F1 transcription factor.
Stubbs MC; Strachan GD; Hall DJ
Biochem Biophys Res Commun; 1999 Apr; 258(1):77-80. PubMed ID: 10222238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]